Knee Biologics
Payments companies reported to CMS as associated with Knee Biologics. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Knee Biologics, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Knee Biologics
These are the largest totals companies reported as associated with Knee Biologics. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Wolf | Iowa City, IA | Sports Medicine (Orthopaedic Surgery) | $62,993.74 |
| Orr Limpisvasti | Los Angeles, CA | Sports Medicine (Orthopaedic Surgery) | $17,217.70 |
| Joshua Dines | Uniondale, NY | Orthopaedic Surgery | $17,217.70 |
| Seth Sherman | Stanford, CA | Sports Medicine (Orthopaedic Surgery) | $16,850.00 |
| Don Buford | Dallas, TX | Sports Medicine (Orthopaedic Surgery) | $12,876.79 |
| David Flanigan | Columbus, OH | Sports Medicine (Orthopaedic Surgery) | $3,575.00 |
| Cassandra Lee | Sacramento, CA | Sports Medicine (Orthopaedic Surgery) | $2,000.00 |
| Deryk Jones | San Carlos, CA | Sports Medicine (Orthopaedic Surgery) | $600.00 |
Prescribed Knee Biologics?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.